Ground News

See It All. Understand It All.

The Dispatch image

News from The Dispatch

See all of The Dispatch’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

We’ve aggregated 712 of The Dispatch’s headlines and news stories over the past 3 months.

The Dispatch’s media bias is Lean Right. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media, a leanRight rating from Media Bias/Fact Check .

Is The Dispatch credible or reliable? Our Factuality score answers both of those questions. When it comes to The Dispatch, we’ve assigned a Very High factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about The Dispatch

Where is The Dispatch located?The Dispatch's Website

Media Bias Ratings

Average Bias Rating:

Lean Right

Center

byAd Fontes Media

Lean Right

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top The Dispatch News

FDA Clears First Blood Test to Reliably Predict Alzheimer’s Disease

Alzheimer's Disease · United States

FDA Clears First Blood Test to Reliably Predict Alzheimer’s Disease

66% Center coverage: 156 sources

2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH

2025 EASL Congress Spotlight: CG-0416 Preclinical Data Unveils A Groundbreaking Dual-Action Therapy Targeting Obesity and MASH

56% Center coverage: 32 sources

——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation See the Story

Kasowitz Wins Appeal on Behalf of Fintiv in Patent Infringement Lawsuit Against Apple

Apple · New York

Kasowitz Wins Appeal on Behalf of Fintiv in Patent Infringement Lawsuit Against Apple

53% Center coverage: 30 sources

NEW YORK, May 16, 2025 /PRNewswire/ -- Kasowitz Benson Torres LLP, a national litigation firm based in New York, announced today that it has achieved a major victory in a patent infringement lawsuit for its client, Fintiv, Inc., a global…See the Story

Breaking News Topics Related to The Dispatch